Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2011 Feb 1;123(3):117–119. doi: 10.1007/s00508-010-1526-7

Novel observations during extracorporeal membrane oxygenation in patients with ARDS due to the H1N1 pandemic influenza

Neu beobachtete Phänomene während des Einsatzes der extracorporalen Membranoxygenation (ECMO) bei ARDS als Folge einer H1N1 pandemischen Influenza

Marko Kutleša 1,, Marija Santini 1, Vladimir Krajinović 1, Dinko Raffanelli 1, Bruno Baršić 1
PMCID: PMC7102324  PMID: 21191657

Summary

We report four patients with novel observations during extracorporeal membrane oxygenation support (ECMO). ECMO was initiated because of severe ARDS due to the primary H1N1 pandemic influenza pneumonia. Two patients had excessive conjugated hyperbilirubinemia and two had unproportional depletion of the coagulation factor IX. Pathogenetic mechanisms and clinical relevance of the noticed phenomena are discussed.

Keywords: Extracorporeal membrane oxygenation, Hyperbilirubinemia, Factor IX, Pandemic H1N1 influenza, Cholestasis

References

  1. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA. 2009;302:1888–1895. doi: 10.1001/jama.2009.1535. [DOI] [PubMed] [Google Scholar]
  2. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, CESAR trial collaboration et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374:1351–1363. doi: 10.1016/S0140-6736(09)61069-2. [DOI] [PubMed] [Google Scholar]
  3. Abbasi S, Stewart DL, Radmacher P, Adamkin D. Natural course of cholestasis in neonates on extracorporeal membrane oxygenation (ECMO): 10-year experience at a single institution. ASAIO J. 2008;54:436–438. doi: 10.1097/MAT.0b013e31817f588a. [DOI] [PubMed] [Google Scholar]
  4. Hermans C, Altisent C, Batorova A, Chambost H, De Moerloose P, Karafoulidou A, et al. European Haemophilia Therapy Standardisation Board. Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations. Haemophilia. 2009;15:639–635. doi: 10.1111/j.1365-2516.2008.01950.x. [DOI] [PubMed] [Google Scholar]

Articles from Wiener Klinische Wochenschrift are provided here courtesy of Nature Publishing Group

RESOURCES